Citation:Stevens R, Macbeth F, Toy E, Coles B, Lester JF 2015

Citation

Stevens R, Macbeth F, Toy E, Coles B, Lester JF. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer. Cochrane Database Syst Rev 2015 Jan 1;1:CD002143 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25553505.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Stevens R, Macbeth F, Toy E, Coles B, Lester JF 2015	What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?	Dr Margot Lehman MBBS FRANZCR GDP	completed
Stevens R, Macbeth F, Toy E, Coles B, Lester JF 2015 1	What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?	Associate Professor Shalini Vinod MBBS MD FRANZCR	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy?|]] (compare critical appraisals)
• [[Clinical question:What is the clinical benefit of radiotherapy to the lung primary in Stage IV NSCLC?|]] (compare critical appraisals)

Cited by

1. Emma.dickins/Sandbox
2. What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?
3. What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?